1. Rui P KK. National Hospital Ambulatory Medical Care Survey: 2017 emergency department summary tables. . National Center for Health Statistics. 2017.
2. Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nature reviews Rheumatology. 2015;11(1):45-54.
3. Hak DJ, Fitzpatrick D, Bishop JA, et al. Delayed union and nonunions: epidemiology, clinical issues, and financial aspects. Injury. 2014;45 Suppl 2:S3-7.
4. Pajarinen J, Lin T, Gibon E, et al. Mesenchymal stem cell-macrophage crosstalk and bone healing. Biomaterials. 2019;196:80-89.
5. Kostenuik P, Mirza FM. Fracture healing physiology and the quest for therapies for delayed healing and nonunion. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2017;35(2):213-223.
6. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. Journal of cellular biochemistry. 2003;88(5):873-884.
7. Bais M, McLean J, Sebastiani P, et al. Transcriptional analysis of fracture healing and the induction of embryonic stem cell-related genes. PloS one. 2009;4(5):e5393.
8. Loi F, Córdova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB. Inflammation, fracture and bone repair. Bone. 2016;86:119-130.
9. Thompson Z, Miclau T, Hu D, Helms JA. A model for intramembranous ossification during fracture healing. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2002;20(5):1091-1098.
10. Bastian O, Pillay J, Alblas J, Leenen L, Koenderman L, Blokhuis T. Systemic inflammation and fracture healing. Journal of leukocyte biology. 2011;89(5):669-673.
11. Polimeni G, Xiropaidis AV, Wikesjö UM. Biology and principles of periodontal wound healing/regeneration. Periodontology 2000. 2006;41:30-47.
12. Wu AC, Raggatt LJ, Alexander KA, Pettit AR. Unraveling macrophage contributions to bone repair. BoneKEy reports. 2013;2:373.
13. Kon T, Cho TJ, Aizawa T, et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2001;16(6):1004-1014.
14. Timlin M, Toomey D, Condron C, et al. Fracture hematoma is a potent proinflammatory mediator of neutrophil function. The Journal of trauma. 2005;58(6):1223-1229.
15. Caplan AI. Mesenchymal stem cells. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 1991;9(5):641-650.
16. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell stem cell. 2008;2(4):313-319.
17. Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cellular and molecular life sciences : CMLS. 2019;76(17):3323-3348.
18. Galipeau J, Sensébé L. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell stem cell. 2018;22(6):824-833.
19. Trounson A, McDonald C. Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell stem cell. 2015;17(1):11-22.
20. Yin JQ, Zhu J, Ankrum JA. Manufacturing of primed mesenchymal stromal cells for therapy. Nature biomedical engineering. 2019;3(2):90-104.
21. Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: An Update. Cell transplantation. 2016;25(5):829-848.
22. Schroder WA, Major L, Suhrbier A. The role of SerpinB2 in immunity. Critical reviews in immunology. 2011;31(1):15-30.
23. Gettins PG. Serpin structure, mechanism, and function. Chemical reviews. 2002;102(12):4751-4804.
24. Medcalf RL, Stasinopoulos SJ. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. The FEBS journal. 2005;272(19):4858-4867.
25. Ritchie H, Jamieson A, Booth NA. Regulation, location and activity of plasminogen activator inhibitor 2 (PAI-2) in peripheral blood monocytes, macrophages and foam cells. Thrombosis and haemostasis. 1997;77(6):1168-1173.
26. Robinson NA, Lapic S, Welter JF, Eckert RL. S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. The Journal of biological chemistry. 1997;272(18):12035-12046.
27. Kruithof EK, Baker MS, Bunn CL. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood. 1995;86(11):4007-4024.
28. Silverman GA, Whisstock JC, Askew DJ, et al. Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cellular and molecular life sciences : CMLS. 2004;61(3):301-325.
29. Schroder WA, Major LD, Le TT, et al. Tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis. Cancer medicine. 2014;3(3):500-513.
30. Socorro M, Shinde A, Yamazaki H, et al. Trps1 transcription factor represses phosphate-induced expression of SerpinB2 in osteogenic cells. Bone. 2020;141:115673.
31. Kanno Y, Ishisaki A, Kawashita E, et al. Plasminogen/Plasmin Modulates Bone Metabolism by Regulating the Osteoblast and Osteoclast Function*. Journal of Biological Chemistry. 2011;286(11):8952-8960.
32. Nordstrom SM, Carleton SM, Carson WL, Eren M, Phillips CL, Vaughan DE. Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization. Bone. 2007;41(6):995-1004.
33. Elsafadi M, Shinwari T, Al-Malki S, et al. Convergence of TGFβ and BMP signaling in regulating human bone marrow stromal cell differentiation. Sci Rep. 2019;9(1):4977-4977.
34. Larsen KH, Frederiksen CM, Burns JS, Abdallah BM, Kassem M. Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2010;25(4):796-808.
35. Ogawa E, Maruyama M, Kagoshima H, et al. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proceedings of the National Academy of Sciences of the United States of America. 1993;90(14):6859-6863.
36. Komori T. Regulation of skeletal development by the Runx family of transcription factors. Journal of cellular biochemistry. 2005;95(3):445-453.
37. Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nature Medicine. 2013;19(2):179-192.
38. Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science (New York, NY). 2002;296(5573):1644-1646.
39. Duan P, Bonewald LF. The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth. Int J Biochem Cell Biol. 2016;77(Pt A):23-29.
40. Cadigan KM, Peifer M. Wnt signaling from development to disease: insights from model systems. Cold Spring Harbor perspectives in biology. 2009;1(2):a002881.
41. Kikuchi A, Yamamoto H, Sato A. Selective activation mechanisms of Wnt signaling pathways. Trends in cell biology. 2009;19(3):119-129.
42. Hausmann G, Bänziger C, Basler K. Helping Wingless take flight: how WNT proteins are secreted. Nature reviews Molecular cell biology. 2007;8(4):331-336.
43. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annual review of cell and developmental biology. 2004;20:781-810.
44. He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development (Cambridge, England). 2004;131(8):1663-1677.
45. Hang K, Ye C, Xu J, et al. Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt/beta-catenin signaling pathway. Stem cell research & therapy. 2019;10(1):189.
46. Harry LE, Sandison A, Paleolog EM, Hansen U, Pearse MF, Nanchahal J. Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2008;26(9):1238-1244.
47. Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ, Nanchahal J. TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(4):1585-1590.